Variable | Total | AN | BN | p value |
---|---|---|---|---|
Minimum BMI (kg/m2) | 16.2 (14.6–18.7) | 15.75 (14–16.4) | 19.4 (16.9–22.8) | 0.00 |
Current BMI (kg/m2) | 19 (17.1–20.8) | 18 (16.5–19.7) | 22.3 (19–25.3) | 0.04 |
Recovered BMI (%) | 12.74 (7.1–26) | 14.6 (7.6–25.2) | 10.4 (2.5–26.7) | 0.64 |
Mental comorbidity | 49 (73.1%) | 33 (73.3%) | 16 (72.7%) | 0.958 |
Suicide behavior disorder | 9 (13.4%) | 5 (11.1%) | 4 (18.2%) | 0.425 |
Substance use disorder | 10 (14.9%) | 5 (11.1%) | 5 (22.7%) | 0.210 |
CKD/nephrocalcinosis | 4 (6%) | 2 (4.4%) | 2 (9.1%) | 0.451 |
Digestive alterations Chronic constipation Gastroesophageal reflux | 19 (28.4%) 13 (19.7%) 12 (17.9%) | 14 (31.1%) 9 (20%) 8 (17.8%) | 5 (22.7%) 4 (18.2%) 4 (18.2%) | 0.475 0.860 0.968 |
Ionic disorders | 13 (19.4%) | 8 (17.8%) | 5 (22.7%) | 0.630 |
Osteoporosis | 27 (40.3%) | 22 (48.9%) | 5 (22.7%) | 0.04 |
Hypogonadotropic hypogonadism | 15 (22.4%) | 14 (31.1%) | 1 (4.5%) | 0.014 |
Endocrinology Ward admissions | 1 (0–2) | 1 (0–3.5) | 0 (0–1.25) | 0.261 |
Days of admission to Endocrinology ward | 13.5 (9.7–19.7) | 14,5 (9.7–23.5) | 12 (8.5–13.7) | 0.225 |
Exitus | 1 (1.5%) | 1(2.2%) | 0(0%) |